Novel blood test shows promise in detecting early-stage cancers with high accuracy

Researchers develop a novel plasma proteome-based test for early detection of multiple cancers, achieving high accuracy in identifying low-abundance protein biomarkers.

Sanofi completes the $1.7bn acquisition of Inhibrx – Pharmaceutical Technology

Sanofi made the $1.7bn purchase of Inhibrx in January 2024. Credits: JHVEPhoto/Shutterstock.com After declaring its intention to purchase Inhibrx for $1.7bn in January, Sanofi has

May 30, 2024

Bristol Myers pays $350M upfront for rights to heart drug Camzyos in Asia

Bristol Myers Squibb is setting up a deal with Shanghai-based LianBio to get the rights to the heart drug Camzyos in China and several other

October 25, 2023

Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC

Adding tislelizumab to neoadjuvant chemotherapy followed by adjuvant use of the investigational PD-1 inhibitor improved event-free survival (EFS) in resectable non-small cell lung cancer (NSCLC),

February 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.